Jennison Associates LLC Standard Biotools Inc. Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$5.5 - $7.41 $741,163 - $998,549	-134,757 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$4.35 - $6.35 $159,658 - $233,064	-36,703 Reduced 21.41%	134,757 $830,000
Q1 2021 May 11, 2021	BUY	$3.94 - $7.09 $94,516 - $170,082	23,989 Added 16.27%	171,460 $775,000
Q4 2020 Feb 05, 2021	BUY	$5.45 - $8.65 $803,716 - $1.28 Million	147,471 New	147,471 $885,000
Q3 2018 Nov 08, 2018	SELL	$5.92 - $8.35 $407,242 - $574,404	-68,791 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$4.86 - $6.24 $138,607 - $177,964	28,520 Added 70.82%	68,791 $410,000
Q1 2018 Apr 20, 2018	BUY	$5.75 - $7.97 $231,558 - $320,959	40,271 New	40,271 $235,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $138M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.